158 related articles for article (PubMed ID: 36155904)
1. Epidemiology of dyslipidemia in Tunisia, HSHS 3 study (Hammam Sousse Sahloul Heart Study).
Ben Hdia Z; Ben Abdelaziz A; Melki S; Ben Hassine D; Ben Rejeb N; Omezzine A; Bouslama A; Ben Abdelaziz A
Tunis Med; 2022 avril; 100(4):323-334. PubMed ID: 36155904
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of diabetes mellitus in Tunisia. HSHS 2 study (Hammam Sousse Sahloul Heart Study).
Mbarki S; Ben Abdelaziz A; Ben Hassine D; Melki S; Ben Rejeb N; Omezzine A; Bouslama A; Ben Abdelaziz A
Tunis Med; 2022 mars; 100(3):229-240. PubMed ID: 36005915
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of arterial hypertension in Tunisia: Hammam Sousse Sahloul Heart Study (HSHS).
Hamoudi A; Ben Abdelaziz A; Melki S; Ben Hassine D; Ben Rejeb N; Omezzine A; Bouslama A; Ben Abdelaziz A
Tunis Med; 2022 fevrier; 100(2):167-179. PubMed ID: 35852253
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
[TBL] [Abstract][Full Text] [Related]
6. [Lipid profile comparison between pre- and post-menopausal women].
Wang N; Qin MZ; Cui J
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
[No Abstract] [Full Text] [Related]
7. Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study.
Stergiou GS; Ntineri A; Menti A; Kalpourtzi N; Vlachopoulos C; Liberopoulos EN; Rallidis L; Richter D; Gavana M; Vantarakis A; Chlouverakis G; Hajichristodoulou C; Trypsianis G; Voulgari PV; Alamanos Y; Karakosta A; Touloumi G
Hellenic J Cardiol; 2023; 69():1-8. PubMed ID: 36243397
[TBL] [Abstract][Full Text] [Related]
8. Association of exposures to serum terpenes with the prevalence of dyslipidemia: a population-based analysis.
Ba Y; Guo Q; Meng S; Tong G; He Y; Guan Y; Zheng B
Environ Sci Pollut Res Int; 2023 Nov; 30(54):115295-115309. PubMed ID: 37880399
[TBL] [Abstract][Full Text] [Related]
9. [The gender features of disorders of composition of lipids of blood serum in patients with chronic pathology of kidneys.].
Murkamilov IT; Aytabaiev KA; Fomin VV; Murkamilova ZA; Rayimjanov ZR; Redjapova NA; Yusupov FA; Aydarov ZA
Klin Lab Diagn; 2018; 63(3):152-158. PubMed ID: 30673194
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
[TBL] [Abstract][Full Text] [Related]
11. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Blais JE; Huang X; Zhao JV
Drugs; 2023 Apr; 83(5):403-427. PubMed ID: 36941490
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of obesity in Tunisia: HSHS4 study (Hammam Sousse Sahloul Heart Study).
Khelil M; Ben Abdelaziz A; Zanina Y; Yahia F; Ben Hassine D; Ben Rejeb N; Omezzine A; Bouslama A; Ben Abdelaziz A
Tunis Med; 2022 juillet; 100(7):551-560. PubMed ID: 36571745
[TBL] [Abstract][Full Text] [Related]
13. Dietary Patterns and the Risk of Dyslipidemia in Korean Adults: A Prospective Cohort Study Based on the Health Examinees (HEXA) Study.
Kim SA; Shin S
J Acad Nutr Diet; 2021 Jul; 121(7):1242-1257.e2. PubMed ID: 33158796
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence trends and related factors of hypertension patients complicating with dyslipidemia in community of Guandong province between 2013 and 2018].
Huang YQ; Li J; Chen JY; Feng YQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Oct; 49(10):986-992. PubMed ID: 34674436
[No Abstract] [Full Text] [Related]
16. Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
Ali N; Samadder M; Kathak RR; Islam F
PLoS One; 2023; 18(1):e0280672. PubMed ID: 36662845
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dyslipidemia and its associated factors among university academic staff and students in Bangladesh.
Ali N; Kathak RR; Fariha KA; Taher A; Islam F
BMC Cardiovasc Disord; 2023 Jul; 23(1):366. PubMed ID: 37479968
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein lipids and the prevalence of hyperlipidaemia in rural India.
Gupta R; Gupta HP; Kumar N; Joshi AK; Gupta VP
J Cardiovasc Risk; 1994 Aug; 1(2):179-84. PubMed ID: 7606632
[TBL] [Abstract][Full Text] [Related]
19. Associations between serum cholinesterase and incident hyper-LDL cholesterolemia, hypertriglyceridemia and hypo-HDL cholesterolemia as well as changes in lipid levels in a health screening population.
Oda E
Atherosclerosis; 2015 Jul; 241(1):1-5. PubMed ID: 25935113
[TBL] [Abstract][Full Text] [Related]
20. The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.
Hong N; Lin Y; Ye Z; Yang C; Huang Y; Duan Q; Xie S
Front Immunol; 2022; 13():937201. PubMed ID: 36032093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
